IFN-gamma pretreatment augments immune complex-induced matrix metalloproteinase-1 expression in U937 histiocytes

Clin Immunol. 2002 Feb;102(2):200-7. doi: 10.1006/clim.2001.5161.

Abstract

We reported recently that immune complexes (ICs) induced matrix metalloproteinase-1 (MMP-1) expression in U937 histiocytes. The present study was undertaken to determine the effect of pretreatment of U937 cells with interferon-gamma (IFN-gamma) on IC-induced MMP-1 expression. Our flow cytometry studies showed that IFN-gamma upregulated the surface expression of FcgammaRI, but not FcgammaRII. Results also showed that pretreatment of the cells with IFN-gamma augmented LDL-containing IC (LDL-IC)-induced MMP-1 secretion in a dose- and time-dependent manner. Furthermore, Northern blot analysis revealed that IFN-gamma pretreatment led to a marked increase in MMP-1 mRNA. Finally, we demonstrated that PD98059 was able to block LDL-IC-induced MMP-1 secretion, regardless of whether the cells were pretreated with IFN-gamma or not, suggesting that IFN-gamma pretreatment did not alter the essential role of the ERK signaling pathway in LDL-IC-induced MMP-1 expression. In conclusion, the present study has demonstrated that IFN-gamma pretreatment augments LDL-IC-induced MMP-1 expression in U937 cells, thus elucidating an immune mechanism potentially involved in plaque destabilization.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antigen-Antibody Complex / immunology*
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / pharmacology
  • Histiocytes / enzymology*
  • Histiocytes / immunology
  • Humans
  • Interferon-gamma / immunology*
  • Interferon-gamma / pharmacology
  • Matrix Metalloproteinase 1 / biosynthesis*
  • Matrix Metalloproteinase 1 / immunology
  • U937 Cells
  • Up-Regulation / drug effects
  • Up-Regulation / immunology

Substances

  • Antigen-Antibody Complex
  • Enzyme Inhibitors
  • Flavonoids
  • Interferon-gamma
  • Matrix Metalloproteinase 1
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one